Abstract |
These recommendations concern the use of aluminum hydroxide adsorbed cell-free anthrax vaccine (Anthrax Vaccine Adsorbed [AVA], BioPort Corporation, Lansing, MI) in the United States for protection against disease caused by Bacillus anthracis. In addition, information is included regarding the use of chemoprophylaxis against B. anthracis.
|
Authors | Advisory Committee on Immunization Practices |
Journal | MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports
(MMWR Recomm Rep)
Vol. 49
Issue RR-15
Pg. 1-20
(Dec 15 2000)
ISSN: 1057-5987 [Print] United States |
PMID | 11145529
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Anthrax
(prevention & control)
- Anthrax Vaccines
(administration & dosage, adverse effects)
- Antibiotic Prophylaxis
- Contraindications
- Humans
- United States
- Vaccination
(standards)
|